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Encoding Medication Episodes for Adverse
Drug Event Prediction
Honghan Wu and Zina M. Ibrahim and Ehtesham Iqbal and Richard JB Dobson
Abstract Understanding the interplay among the multiple factors leading to Ad-
verse Drug Reactions (ADRs) is crucial to increasing drug effectiveness, individu-
alising drug therapy and reducing incurred cost. In this paper, we propose a flexible
encoding mechanism that can effectively capture the dynamics of multiple medica-
tion episodes of a patient at any given time. We enrich the encoding with a drug
ontology and patient demographics data and use it as a base for an ADR predic-
tion model. We evaluate the resulting predictive approach under different settings
using real anonymised patient data obtained from the EHR of the South London and
Maudsley (SLaM), the largest mental health provider in Europe. Using the profiles
of 38,000 mental health patients, we identified 240,000 affirmative mentions of dry
mouth, constipation and enuresis and 44,000 negative ones. Our approach achieved
93% prediction accuracy and 93% F-Measure.
1 Introduction
Adversities associated with prescribed mediation can seriously affect the patient’s
wellbeing [1] and present a real financial burden on healthcare providers (estimated
to lead to an annual cost of 466 million pounds in the United Kingdom alone [3]).
The problem arises from the fact that trial-tested prescribed drugs are not evalu-
ated for long-term effectiveness in diverse (and possibly comorbid) patient popu-
lations, resulting in many unknowns with respect to the possibilities of the onset
of adverse drug reactions (ADRs). Currently, discovering the factors affecting pa-
tients’ response to treatment relies on spontaneous reporting systems that rely on
patient and clinician data entry and resulting highly under-reported ADR instances
[5]. However, there is a large body of unutilised knowledge embedded in the Elec-
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tronic Health Records (EHRs) of hospitals, containing valuable information regard-
ing treatment responses as well as patient profiles and disease trajectories.
Analysing the factors associated with ADRs using EHRs resolves to the task
of uncovering the temporal associations connecting the different factors. Things
are more complicated in long-term debilitating and comorbidity illnesses whereby
ADRs are associated with multiple, overlapping and long medication episodes.
From a technical perspective, a challenging task lies in modelling the time series
of medication episodes in an effective way so that they can be fed with other influ-
encing factors into predictive algorithms.
In this paper, we propose a bitwise encoding mechanism that can capture the
temporal precedence and duration information of medication episodes as well as
their distance from the time of inspection. We present an initial study of using the
resulting model to predict the onset of three ADRs, mainly dry mouth, constipation
and enuresis, from a large mental health register.
2 Temporal Encoding for Patient’s Medication Episodes
Here, we present the novel vector-based encoding of dynamic and multiple medica-
tion episodes. Figure 1 illustrates an example encoding scenario. The upper part
shows the sample medication episodes of a patient that are related to a certain
inspecting time spot (marked as AE date in the figure). The encoding is realised
through the following steps.
0 1 2 3 
AE Date 
M1 
M2 
M3 
0 1 2 3 Code 
M1 0 0 0 1 1 
M2 0 1 1 0 6 
M3 1 0 0 0 8 
Time 
Numbered intervals 
Medica'on	Vector	related	to	an	AE	Event	
Fig. 1 The bitwise encoding of dynamic medication episodes for a given adverse event
1. From the the inspecting time spot, look back to a certain period of time, e.g., 20
days. In our experiments, we selected 30 days.
2. Split the time period into intervals using a unit of time, e.g., a day or a week.
Number each interval in an ascendent order (started from zero) starting from the
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inspecting time spot. For example, 4 intervals are identified and numbered in
Figure 1
3. Add the patient’s medication episodes to the timeline.
4. For each medication episode, allocate a sequence of bits aligned with the interval
order we obtained in step 2. The interval numbered zero is aligned with the most
significant bit in the sequence. For each interval, set the corresponding bit to
1 if the interval intersects with the episode, and to 0 otherwise. For example,
Medication Episode 2 (M2) in Figure 1 spans across interval number 1 and 2. Its
encoding is 0110 in binary code.
5. Repeat step 4 for all medication episodes. We will get a vector representing all
the relevant medication episodes of the inspecting time spot.
2.1 Predictive Model
Having illustrated the encoding of the temporal information embedded within med-
ication episodes, we now show how this information can be combined with addi-
tional background knowledge as well as external ontologies into a feature vector for
prediction.
Our predictive model considers two sets of features: 1) demographics, 2) the
generated dynamic medication episodes which are further enriched by an ontology.
Equation 1 shows the features of demographic information of a patient p at a given
time t where age@t means the patient’s age at the inspecting time t.
Fd(p, t) = (age@t, gender, ethnicity) (1)
Equation 2 gives the feature calculation from dynamic medication episodes given
a patient p, an adverse event type a and a time t.
Fm(p, a, t) = (α · diag(Sa) + diag(1)) ·Mp,t (2)
Sa is a binary vector describing drugs’ relation with side effect a. For example,
suppose there are two drugs (d1, d2), and d1 has the side effect a but d2 does not.
Then, the Sa is [1, 0]. Such vector is derived from the drug ontology. Mp,t is the
vector generated from the medication episodes of the patient p at a given time t using
our encoding method. α is the weighting factor for adjusting side effect knowledge
importance in the final prediction model.
The final feature vector for prediction is a concatenation of the above two as
shown in equation 3. In this paper, we view the ADR prediction as a classification
problem. Therefore, the feature vector is used as the inputs for training and testing
classification algorithms on our datasets. Various classifiers have been tested. The
experiment section will give the detail about model selection.
F (p, a, t) = (Fm(p, a, t), Fd(p, t)) (3)
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3 Implementation and Evaluation
Data Source and Preparation
We used data extracted from the Clinical Record Interactive Search System (CRIS)
[4] to evaluate our encoding. CRIS is a database containing a de-identified replica
of the EHRs used by the South London and Maudsley Foundation Trust (SLaM),
the largest mental health provider in Europe. SLaM serves over 1.2 million patients
and stores much of its clinical records and prescribing information in unstructured
free text format. The ADR and drug episode information were extracted using an
in-house developed natural language processing tools in conjunction with manual
annotation [2]
In this preliminary study, we focus on three types of adverse events identified
in the CRIS registry: dry mouth (#event 58,347), constipation (#event 86,602) and
enuresis (#93,366), which involves 20,795 distinct patients with mental health dis-
orders. For each identified AE, we pick up the patient’s past 30 days medication
episodes. It is worth mentioning that a large proportion (≥ 62% on average) of AEs
are associated with multiple medications. To generate negative data items (none ad-
verse event), we picked 18,038 patients who have medication episode data in CRIS
registry but never had the three types of adverse events reported.
The dataset was split into a proportion of 80/20 for training and testing. 10-folds
cross validation has also been used. The former setting achieved better performance
across three AE types.
Demographic vs Medication Episode Features
We have two types of feature sets - demographic features and medication episode
ones. Comparing their performances will reveal some insights about what factors
are more likely to be associated with adverse events. When only using demographic
features, the F-Measure is around 70%. But for AE class of dry mouth type, the
performance is extremely low - 12% True Positive and 20% F-Measure. Table 1
gives the performance of dynamic medication episode features. In all cases, about
90% F-Measure has been achieved with the lowest at 85% at AE class of dry mouth
and the highest at 96% at none AE class of the same case. In summary, it is quite
obvious that dynamic medication episode features are much better indicators for
predicting Adverse Events. The combination of the two sets of features can achieve
the best results as shown in Table 2. Both average Precision and F-Measure are
around 93%.
Ontology-based Feature Dimension Reduction
The semantics in the drug ontologies can be utilised to combine semantically similar
drugs so that the dimensions of the feature vector Fm (Equation 2) can be reduced
Encoding Medication Episodes for Adverse Drug Event Prediction
Table 1 Medication Episode-Feature Only Results
ADE Type TP Rate FP Rate Precision Recall F-Measure ROC Area Class
Dry Mouth 0.83 0.04 0.86 0.83 0.85 0.97 AE0.96 0.17 0.95 0.96 0.96 0.97 N-AE
Weighted Avg. 0.93 0.14 0.93 0.93 0.93 0.97
Constipation 0.90 0.07 0.92 0.90 0.91 0.97 AE0.93 0.10 0.91 0.93 0.92 0.97 N-AE
Weighted Avg. 0.92 0.08 0.92 0.92 0.92 0.97
Enuresis 0.88 0.07 0.93 0.88 0.90 0.96 AE0.93 0.12 0.88 0.93 0.90 0.96 N-AE
Weighted Avg. 0.90 0.10 0.90 0.90 0.90 0.96
Table 2 Medication Episode and Demographic Combined Results
ADE Type TP Rate FP Rate Precision Recall F-Measure ROC Area Class
Dry Mouth 0.89 0.05 0.85 0.89 0.87 0.98 AE0.95 0.11 0.97 0.95 0.96 0.98 N-AE
Weighted Avg. 0.94 0.10 0.94 0.94 0.94 0.98
Constipation 0.93 0.08 0.91 0.93 0.92 0.97 AE0.92 0.08 0.93 0.92 0.93 0.97 N-AE
Weighted Avg. 0.92 0.08 0.92 0.92 0.92 0.97
Enuresis 0.92 0.09 0.92 0.92 0.92 0.96 AE0.91 0.08 0.91 0.91 0.91 0.96 N-AE
Weighted Avg. 0.92 0.08 0.92 0.918 0.92 0.96
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Fig. 2 Feature Dimension Reduction by Drug Ontology
significantly (from 226 for all drugs to 47 for using direct parent category). The
performance differences between these two settings are illustrated in Figure 2. For
dry mouth and constipation cases, the performances (average classification accu-
racy) decreased in about 1 per cent in average when using drug classes, while the
accuracy did improve in the enuresis case when the feature dimension was reduced.
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This is a very interesting observation worth further investigation to see whether it is
a single special case or the drugs related to enuresis make the case special. Figure 2
also reveals that using less feature dimension can significantly increase the training
speed, which is not surprising.
4 Conclusion
We reported a retrospective study of predicting adverse events in EHRs from South
London and Maudsley Foundation Trust (SLaM), the largest mental health provider
in Europe. The prediction model puts a special focus on effective approaches of
modelling the dynamic and multiple medication episodes, which are very common
among patients with mental health disorders (observed among ≥ 62% events in our
data). Specifically, a novel bitwise encoding approach is introduced for capturing
the medication trajectories, which has proved to be more effective (10% accuracy
improvement) than static medication modelling settings.
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